JCAD Online Editor

rss feed

JCAD Online Editor's Latest Posts

Monoclonal Antibody Therapies for Atopic Dermatitis: Where Are We Now in the Spectrum of Disease Management?

Monoclonal Antibody Therapies for Atopic Dermatitis: Where Are We Now in the Spectrum of Disease Management?

| February 1, 2019

This ongoing column explores emerging treatment options, drug development trends, and pathophysiologic concepts in the field of dermatology.  J Clin Aesthet Dermatol. 2019;12(2):39–43 by James Q. Del Rosso, DO Dr. Del Rosso is Research Director of JDR Dermatology Research in Las Vegas, Nevada; is with Thomas Dermatology in Las Vegas, Nevada; and is Adjunct Clinical […]

Continue Reading

Vitamin C Prevents Ultraviolet-induced Pigmentation in Healthy Volunteers: Bayesian Meta-analysis Results from 31 Randomized Controlled versus Vehicle Clinical Studies

Vitamin C Prevents Ultraviolet-induced Pigmentation in Healthy Volunteers: Bayesian Meta-analysis Results from 31 Randomized Controlled versus Vehicle Clinical Studies

| February 1, 2019

 J Clin Aesthet Dermatol. 2019;12(2):E53–E59 (epub only) by Romain de Dormael, PharmD;* Philippe Bastien, PhD;* Peggy Sextius, PhD; Audrey Gueniche, PharmD; Daniel Ye, PhD; Christian Tran, PharmD; Véronique Chevalier, MSc; Charles Gomes, PhD; Luc Souverain, MSc; and Caroline Tricaud, PhD Drs. de Dormael, Bastien, Sextius, Gueniche, Tran, Gomes, and Mr. Souverain are with L’Oréal Research […]

Continue Reading

January 2019 Digital Edition

January 2019 Digital Edition

| January 1, 2019

Click the cover below to access the January 2019 digital edition of JCAD!

Continue Reading

January 2019 Editorial Message

January 2019 Editorial Message

| January 1, 2019

Dear Colleagues:  Welcome to the January 2019 issue of The Journal of Clinical and Aesthetic Dermatology.  We begin the issue with a study titled, “Halobetasol 0.01%/Tazarotene 0.045% Fixed-combination Lotion in the Treatment of Plaque Psoriasis: Sensitization and Irritation Potential.” In this article, Del Rosso et al evaluated the results from two studies that assessed the […]

Continue Reading

Halobetasol 0.01%/Tazarotene 0.045% Fixed-combination Lotion in the Treatment of Plaque Psoriasis: Sensitization and Irritation Potential

Halobetasol 0.01%/Tazarotene 0.045% Fixed-combination Lotion in the Treatment of Plaque Psoriasis: Sensitization and Irritation Potential

| January 1, 2019

 J Clin Aesthet Dermatol. 2019;12(1):11–15 by James Q. Del Rosso, DO; Leon Kircik, MD; Tina Lin PharmD; and Radhakrishnan Pillai, PhD Dr. Del Rosso is with JDR Dermatology Research/Thomas Dermatology in Las Vegas, Nevada. Dr. Kircik is with the Indiana University School of Medicine in Indianapolis, Indiana; Physicians Skin Care, PLLC in Louisville, Kentucky; and […]

Continue Reading

Role, Extent, and Impact of Comorbidity on Prognosis and Survival in Advanced Metastatic Melanoma: A Review

Role, Extent, and Impact of Comorbidity on Prognosis and Survival in Advanced Metastatic Melanoma: A Review

| January 1, 2019

 J Clin Aesthet Dermatol. 2019;12(1):16–23 by Frederick N. Bebe, DrPH; Shasa Hu, MD; Tony L. Brown, MD, PhD; and Orien L. Tulp, MD, PhD Dr. Bebe is with the Kentucky State University College of Agriculture and Food Science and Sustainable Systems in Frankfort, Kentucky. Dr. Hu is with the Miller College of Medicine at the University […]

Continue Reading

Fractionated Carbon Dioxide Laser Resurfacing as an Ideal Treatment Option for Severe Rhinophyma: A Case Report and Discussion

Fractionated Carbon Dioxide Laser Resurfacing as an Ideal Treatment Option for Severe Rhinophyma: A Case Report and Discussion

| January 1, 2019

 J Clin Aesthet Dermatol. 2019;12(1):24–27 by Victoria Comeau DO, PGY II; Marcus Goodman, DO; Mary Margaret Kober, MD; and Christopher Buckley, DO Drs. Comeau, Goodman, and Buckley are with the Department of Dermatology at Philadelphia College of Osteopathic Medicine in Roswell, Georgia. Drs. Goodman, Kober, and Buckley are also with Goodman Dermatology in Roswell, Georgia.  […]

Continue Reading